Disseminated mycobacterial infections after tumor necrosis factor inhibitor use, revealing inborn errors of immunity.
| Autor: | Squire JD; Division of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic, Jacksonville, USA. Electronic address: squire.jacqueline@mayo.edu., Libertin CR; Division of Infectious Diseases, Mayo Clinic, Jacksonville, USA., Powers H; Division of Infectious Diseases, Mayo Clinic, Jacksonville, USA., Nelson J; Division of Infectious Diseases, Mayo Clinic, Jacksonville, USA., Brumble L; Division of Infectious Diseases, Mayo Clinic, Jacksonville, USA., Laham FR; Pediatric Infectious Disease and Immunology Arnold Palmer Hospital for Children at Orlando Health, Orlando, USA., Agharahimi A; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Freeman AF; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Leiding JW; Pediatric Infectious Disease and Immunology Arnold Palmer Hospital for Children at Orlando Health, Orlando, USA; Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University, Baltimore, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Jun; Vol. 131, pp. 162-165. Date of Electronic Publication: 2023 Apr 08. |
| DOI: | 10.1016/j.ijid.2023.04.007 |
| Abstrakt: | Tumor necrosis factor-a inhibitors can be associated with increased risk of infections, particularly reactivation of latent tuberculosis or nontuberculous mycobacterium (NTM). However, because disseminated NTM is rare, inborn errors of immunity should be considered. We present three patients with disseminated NTM after tumor necrosis factor-a inhibitor use who were found to have inborn errors of immunity. Competing Interests: Declaration of competing interest The authors have no competing interests to declare. (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|